Summary
The blood-level of β2-microglobulin (β2-mG) in patients with Graves disease is generally elevated, varying with the condition of the patients. After treatment with Tapazole, the blood level of β2-mG is gradually lowered to normal range with improvement of the disease. In this study the mechanism and significance of such variations of β2-mG in Graves disease patients were investigated by observing suppressor T-lymphocyte function (expressed as suppression index, SI). At the same time the blood levels of β2-mG of the same subjects were determined. It was found that the quantitative variation of the blood β2-mG was related to the condition of patients as well as to the status of immunologic system. The high level of blood β2-mG was probably due to the dysfunction of suppressor T-lymphocytes. The measurement of blood β2-mG was much easier than that of SI, and possibly, the former could be used instead of the latter to show the function of cell-mediated immunity in patients with Graves disease.
Similar content being viewed by others
References
Poulik MD, et al. Eeta 2-microglobulin production and secretion by lymphocytes in culture. J Immunol 1973; 110: 1430–3.
Bach ML, et al. Beta 2-microglobulin: association with lymphocyte receptors. Science 1973; 182: 1350–2.
Goodwin JS, et al. Regulation of the immune response by prostaglandins. Clin Immunol Immunopathol 1980; 15: 106–22.
Stenson WF, et al. Prostaglandins, macrophages, and immunity. J Immunol 1980; 125: 1–5.
Pacini F, et al. Effect of indomethacin on phytohemagglutinin-stimulated peripheral blood lymphocytes in thyroid autoimmune diseases. J Clin Immunol 1982; 2: 335–42.
How J, et al. T lymphocyte sensitization and suppressor T lymphocyte defect in patients long after treatment for Graves disease. Clin Endocrin 1983; 18: 61–71.
Bene MC, et al. Graves disease in situ localization of lymphoid T cell subpopulation. Clin Exp Immunol 1983; 52: 311–6.
Bhalla RB, et al. Abnormally high concentrations of beta 2-microglobulin in acquired immunodeficiency syndrome (AIDS) patients. Clin Chem 1983; 29: 1560.
Simonsson B, et al. Eeta 2-microglobulin in chronic lymphocytic leukemia. Scand J Haematol 1980; 24: 174–80.
Volpe R. The pathogenesis of Graves disease: an overview. Clin Endocrinol Metabol 1978; 7: 3–29.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Xiao-liang, H., Wei-xin, Y. Mechanism and significance of abnormal blood level of β2-microglobulin in patients with Graves’ disease. Journal of Tongji Medical University 8, 35–40 (1988). https://doi.org/10.1007/BF02887775
Issue Date:
DOI: https://doi.org/10.1007/BF02887775